FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry, and concerns a method for preparing acyclovir formulations of better biological availability. Also the invention refers to a unit dosage form of acyclovir, a mode of administration, a method of treating a viral disease, and a method of improving biological availability of acyclovir.
EFFECT: invention provides higher clinical effectiveness in viral infectious diseases in the patient, and reduced number of drug doses with the patient.
16 cl, 2 ex, 2 tbl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING SGLT2 INHIBITORS | 2009 |
|
RU2530494C2 |
| COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS | 2005 |
|
RU2403237C2 |
| COMPOUNDS AND FORMULATIONS FOR ACTIVE SUBSTANCE DELIVERY | 2005 |
|
RU2530889C2 |
| PHOSPHONIC ACID ESTERS AND METHODS FOR SYNTHESIS THEREOF | 2011 |
|
RU2581045C2 |
| PHOSPHONATE DERIVATIVES | 2000 |
|
RU2258707C2 |
| 2-(2-AMINO-1,6-DIHYDRO-6-OXOPURIN-9-YL)METOXY-3-HYDROXY- 1-PROPANYL-L-VALINATE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION AND HYDROXY AND/OR AMINO PROTECTED 2-(2- AMINO-1,6-DIHYDRO-6-OXOPYRIN-9-YL) METHOXY-3-HYDROXY-1- PROPANYL-L-VALINATE | 1995 |
|
RU2133749C1 |
| HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2544010C2 |
| NUCLEOSIDE ANALOGUES WITH CARBOXAMIDINE-MODIFIED MONOCYCLIC BASE | 2001 |
|
RU2259831C2 |
| PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | 2013 |
|
RU2658050C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
